Dr. Ankur Bahl is a highly skilled cancer specialist who has more than 15+ years of rich experience in this field. He is an alumni of Maulana Azad Medical CollegeDelhi from where he did his MBBS, followed by MD Medicine. He has done his DMMedical Oncology from the prestigious AIIMS New Delhi. He has also completeda course on Adverse Drug Reactions, Drug Interactions and Pharma covigilance at the University of Oxford UK. Dr. Bahl holds clinical expertise inImmunotherapy, targeted therapies in combination with Chemotherapy,Hormonal Therapy, Supportive and Palliative Care. He is the lead author of largest real world Indian data on targeted therapy(Cetuxmab) in Head & Neck cancer, Acute Myeloid Leukaemia Treatment,Human Pappiloma Virus trends in Indian Population etc. He is also the leadfounder of various innovative oncology educational platforms and networks(International and national) Evidence based debates in oncology, Live Oncology Tumour boards, Master Classes andworkshops in oncology Dr Bahl has joined FMRI, Gurugram from Max Hospital, Saket where he was Director- Medical Oncology and HaematologyOncology, Previously he was associated with prestigious organisation like Rajiv Gandhi Cancer Institute and ResearchCentre and Maulana Azad Medical College.

• DM Medical Oncology — AIIMS, New Delhi
• Expertise in immunotherapy, targeted therapy, chemotherapy & palliative care
• Currently associated with FMRI, Gurugram
• Former Director, Medical Oncology & Hemato-Oncology — Max Hospital, Saket
• Previously worked at Rajiv Gandhi Cancer Institute & Maulana Azad Medical College
• Lead author of major Indian real-world oncology studies (e.g., Cetuximab in head & neck cancer)
• Founder of oncology education platforms, tumor boards & masterclasses
• Training in pharmacovigilance — University of Oxford, UK
• MBBS,MD,DM